Skip to content

IMMULITE®/IMMULITE® 1000 Systems TES Total Testosterone 10381156Recalls & reported problems

Siemens Healthcare Diagnostics Products Ltd · Testosterone - IMMULITE - RGT - 100 Tests · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

1 other recall cover devices cleared under the same FDA submission (K032881); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Oct 25, 2022Class IIOpen, Classified

    Confirmed an average positive bias of 40% for testosterone concentrations of approximately 660 ng/dL (22.9 nmol/L) and above with the IMMULITE/IMMULITE 1000 Total Testosterone Assay when compared to the IMMULITE 2000/IMMULITE 2000 XPi Total Testosterone Assay. Two (2) lots of Total Testosterone assays for the IMMULITE/IMMULITE 1000, kit lots #515 and #516 were actively distributed to customers when the issue was discovered by Siemens, and they are subject to the correction or removal in this recall (867 total quantity of reagents distributed for each lot). The violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. In both males and female, testosterone results are not used in isolation but are interpreted in conjunction with clinical history and symptomology as well as with other laboratory testing (e.g. gonadotropins and other sex steroids). A delay in the diagnosis may be experienced and medical intervention, such as repeat testing may be required.

    Z-0355-2023 · Root cause: Process control · Recall details · FDA record ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K032881. One submission often covers many models, so check the product and lot details in each record.

  • Z-0528-06 · Jan 3, 2006 · Terminated
    IMMULITE 2000 Total Testosterone Kit

Other RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE devices

All RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page